Objectives

The primary objectives were:

• a) to determine whether insulin glargine-mediated normoglycemia can reduce cardiovascular morbidity and/or mortality in people at high risk for vascular disease with either IFG, IGT, or early type 2 diabetes;
• b) to determine whether omega-3 polyunsaturated fatty acids can reduce cardiovascular mortality in people with IFG, IGT, or early type 2 diabetes.